Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Short Read Sequencing Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The short read sequencing market has seen rapid expansion in recent years. It is forecast to rise from $7.8 billion in 2025 to $9.2 billion in 2026, reflecting a compound annual growth rate (CAGR) of 17.9%. The market’s growth in the past can be linked to the broadening of genomics research initiatives, the reduction in cost per genome sequencing, greater integration of NGS in academic research, the increase in population-scale sequencing studies, and the wider access to sequencing instruments.
The short read sequencing market is poised for substantial expansion in the coming years. It is projected to reach $17.75 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 17.9%. This anticipated growth across the forecast period can be attributed to several factors, including the expanding implementation of precision medicine programs, a heightened need for oncology and rare disease sequencing, the broadened application of clinical diagnostics leveraging NGS, increasing capital allocation towards genomics data infrastructure, and the growing incorporation of AI-driven sequence analysis. Furthermore, key developments expected during this period involve the greater adoption of high-throughput sequencing platforms, a rising imperative for economical whole genome sequencing, deeper integration of advanced bioinformatics pipelines, the proliferation of clinical and translational genomics applications, and an intensified focus on enhancing sequencing accuracy and speed.
Get A Free Sample Report With In-Depth Market Insights:
Short Read Sequencing Market Growth Factors: What’s Supporting Expansion?
The increasing embrace of personalized medicine is a key factor in the future expansion of the short read sequencing market. Personalized medicine involves customizing medical treatments based on an individual’s distinct genetic profile, leading to more effective and targeted healthcare solutions. Short read sequencing is crucial for pinpointing genetic variations that affect how drugs work, which in turn facilitates the creation of individualized treatment strategies. For example, data from February 2024, reported by the US-based nonprofit organization, the Personalized Medicine Coalition, indicated that the USFDA gave approval to 16 new personalized treatments for rare disease patients in 2023, a considerable rise from 6 personalized treatments in 2022. Consequently, the growing integration of personalized medicine will propel the short-read sequencing market forward.
Short Read Sequencing Market Segment Landscape: Which Areas Lead Development?
The short read sequencing market covered in this report is segmented –
1) By Product: Instruments, Consumables, Services
2) By Workflow: Pre-Sequencing, Sequencing, Data Analysis
3) By Application: Clinical Investigation, Oncology, Reproductive Health, Consumer Genomics, Agri genomics And Forensics, HLA Typing Or Immune System Monitoring
4) By End Users: Academic Research, Hospitals And Clinics, Clinical Research, Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Instruments: Next-Generation Sequencing (NGS) Systems, Sequencing Platforms, Library Preparation Systems
2) By Consumables: Reagents And Kits, Flow Cells, Sample Preparation Consumables
3) By Services: Sequencing Services, Data Analysis Services, Bioinformatics Services
Short Read Sequencing Market Industry Trends: What’s Reshaping Demand?
Major companies active in the short-read sequencing market are dedicating efforts to creating advanced solutions, such as hybrid long-/short-read sequencing assays, to extend their analytical reach and enhance access to complex genomic areas. A hybrid long-/short-read sequencing assay is a process that facilitates the generation of both long and short sequencing reads on a single platform, delivering superior genomic detail while maintaining compatibility with standard high-throughput sequencing systems. For instance, in March 2023, Illumina Inc., a US-based firm specializing in DNA sequencing and array technologies, introduced the Illumina Complete Long Read Prep, Human assay. This offering embeds long-read functionality into current short-read sequencing instruments, allowing laboratories to gather comprehensive genomic data without the necessity of separate long-read setups. It also supports low DNA input and provides high accuracy, thereby improving the capacity to analyze genomic regions that are difficult to map while streamlining the overall workflow.
Short Read Sequencing Market Top Companies Driving Competitive Growth
Major companies operating in the short read sequencing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Illumina Inc., Agilent Technologies Inc., QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, BGI Genomics Co Ltd, MGI Tech Co. Ltd., 10x Genomics Inc., Zymo Research Corporation, Paragon Genomics Inc., Novogene Co. Ltd, Macrogen Inc., Fasteris SA, GenScript Biotech Corporation, Element Biosciences Inc., Singular Genomics Systems Inc., Ultima Genomics Inc., GenapSys Inc.
View The Full Short Read Sequencing Market Report:
Short Read Sequencing Market Global Footprint: Which Region Leads The Industry?
North America was the largest region in the Short Read Sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the short read sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
